Clinical Trials Directory

Trials / Sponsors / Par Pharmaceutical, Inc.

Par Pharmaceutical, Inc.

Industry · 36 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermat
Atopic Dermatitis
Phase 32016-06-01
TerminatedBioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Childr
Otitis Media in Patients With Tympanostomy Tubes
Phase 32013-11-01
TerminatedA Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa
Otitis Externa
Phase 32013-07-01
TerminatedTreatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Pati
Anorexia, Cachexia, Weight Loss
Phase 32006-06-01
TerminatedTreatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension
Anorexia, Cachexia, Weight Loss
Phase 32006-06-01
TerminatedEffect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension
Healthy
Phase 12006-05-01
CompletedBioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12006-01-01
CompletedBioavailability Study of Propranolol Under Fed Conditions
To Determine Bioequivalence Under Fed Conditions
Phase 12005-09-01
CompletedBioavailability Study of Propranolol Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 22005-05-01
CompletedBioavailability Study of Oxandrolone Tablets Under Fasting Conditions
To Determine the Bioequivalence Under Fasting Conditions
Phase 12005-03-01
CompletedBioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions
To Determine the Bioavailability of Tranylcypromine
Phase 12004-10-01
CompletedBioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12004-07-01
CompletedBioavailability Study of Clonazepam ODT Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12004-03-01
CompletedBioavailability Study of Clonazepam Tablets Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12004-02-01
CompletedBioavailability Study of Leflunomide Tablets Under Fed Conditions
To Determine Bioequivalence Under Fed Conditions
Phase 12003-12-01
CompletedBioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions
Healthy
Phase 12003-11-01
CompletedBioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
Healthy
Phase 12003-10-01
CompletedBioavailability Study of Leflunomide Tablets Under Fasting Conditions
To Determine the Bioequivalence Study Under Fasting
Phase 12003-06-01
CompletedBioavailability Study of Metronidazole Capsules Under Fed Conditions
To Determine the Bioequivalence Study Under Fed
Phase 12002-08-01
CompletedBioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions
Healthy
Phase 12002-08-01
CompletedBioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions
Healthy
Phase 12002-08-01
CompletedBioavailability Study of Metronidazole Capsules Under Fasting Conditions
To Determine the Bioequivalence Study Under Fasting
Phase 12002-08-01
CompletedBioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12002-05-01
CompletedBioavailability Study of Tramadol/APAP Tablets Under Fed Conditions
To Determine Bioequivalence Under Fed Conditions
Phase 12002-05-01
CompletedBioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12001-08-01
CompletedBioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions
To Determine Bioequivalence Under Fed Conditions
Phase 12001-07-01
CompletedBioavailability Study of Torsemide Tablets Under Fed Conditions
Healthy
Phase 12001-04-01
CompletedBioavailability Study of Torsemide Tablets Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12001-04-01
CompletedBioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 12000-01-01
CompletedBioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions
To Determine Bioequivalence Under Fed Conditions
Phase 11999-11-01
CompletedBioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 11999-09-01
CompletedA Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study
To Determine Bioequivalence Under Fed Conditions
Phase 11999-08-01
CompletedBioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions
To Determine Bioequivalence Under Fed Conditions
Phase 11999-07-01
CompletedComparative Bioavailability Study of Lisinopril Tablets, 10 mg
Healthy
Phase 11999-06-01
CompletedBioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions
To Determine Bioequivalence Under Fed Conditions
Phase 11998-07-01
CompletedBioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions
To Determine Bioequivalence Under Fasting Conditions
Phase 11998-06-01